Many publicly accessible AI assistants lack adequate safeguards to prevent mass health disinformation

Effective processes for reporting and responding to safeguard vulnerabilities are also lacking, warn experts Many publicly accessible artificial intelligence (AI) assistants lack adequate safeguards to consistently prevent the mass generation of health disinformation across a broad range of topics, warn experts in The BMJ today. They call for enhanced regulation, ...

2024-06-04T10:23:17+00:0021 March 2024|Press release, The BMJ|

Significant proportion of cancer drugs lack proof of added benefit

Particularly those approved through “fast track” pathways Many cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved through expedited (“fast track”) pathways, finds a study published by The BMJ today. And despite pharmaceutical industry claims that high drug prices are ...

2024-06-04T10:24:26+00:0029 February 2024|Press release, The BMJ|

Consistent evidence links ultra-processed food to over 30 damaging health outcomes

Findings underscore need for urgent research to understand how ultra-processed foods affect health and measures to target and reduce exposure Consistent evidence shows that higher exposure to ultra-processed foods is associated with an increased risk of 32 damaging health outcomes including cancer, major heart and lung conditions, mental health disorders, ...

2024-06-04T10:23:53+00:0029 February 2024|Press release, The BMJ|

The BMJ reveals huge delays in dealing with complaints against UK drug companies

Delays allow problematic practices to carry on for many months Processing times for complaints against drug companies suspected of having breached their industry code of practice have more than tripled in a nearly two-decade period, an investigation by The BMJ has found. Data analysis by Shai Mulinari at Lund University and Piotr ...

2024-06-04T10:24:26+00:0015 February 2024|Press release, The BMJ|
Go to Top